Medicine Description selectomycin-d 0.3%
Selectomycin-D 0.3% Eye Drops is a medication that combines dexamethasone and tobramycin to address both inflammation and infection in the eye. Dexamethasone, a synthetic glucocorticoid, operates by binding to specific cytoplasmic glucocorticoid receptors, leading to the formation of a receptor complex that translocates into the nucleus. Here, it modulates the transcription of genes responsible for producing anti-inflammatory proteins and suppressing pro-inflammatory mediators. This action primarily involves the upregulation of lipocortins, which inhibit phospholipase A2, thus reducing the synthesis of inflammatory mediators such as prostaglandins and leukotrienes. Together with tobramycin, which is an aminoglycoside antibiotic that disrupts bacterial protein synthesis by binding to the 30S ribosomal subunit, Selectomycin-D effectively diminishes ocular inflammation while preventing or treating bacterial infections.
Indications and Uses of Selectomycin-D 0.3% Eye Drops
- Management of ocular inflammation associated with allergic conjunctivitis.
- Treatment of bacterial infections of the eye, especially when caused by susceptible strains.
- Post-operative inflammation control in patients undergoing ocular surgery.
Side Effects of Selectomycin-D 0.3% Eye Drops
- Burning or stinging sensation upon application.
- Redness or irritation of the eye.
- Increased intraocular pressure with prolonged use.
- Potential allergic reactions including itching and rash.
- Vision changes or blurriness.
Storage and Handling
Store Selectomycin-D 0.3% Eye Drops in a cool, dry place at room temperature, away from direct sunlight. Ensure the bottle is tightly closed when not in use and keep out of reach of children.
Patient Advice and Precautions
Patients should be advised to avoid touching the dropper tip to any surface to prevent contamination. It is crucial to follow the healthcare provider's instructions regarding application frequency and duration. If experiencing persistent discomfort or visual disturbances, patients should seek medical advice promptly. Individuals should also inform their healthcare provider of any other medications they are using to prevent potential interactions.